A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
N/A. We will recruit all non-melanoma skin and bladder cancer patients
that are recommended for surgical removal of tumor tissues. This includes patients from
all ages, gender and ethnicity background. Our sample collection criteria based on the
tumor size of individual (e.g. tumor samples will only be collected if it will not affect
the pathological diagnosis or treatment procedures of patients).
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
Measurement of cancer stem cells (CSCs)
Outcome Time Frame:
The current study does not include the active involvement of patients. Our study involves the collection of tumor samples from patients after surgical procedures.
Irving L. Weissman M.D.
United States: Institutional Review Board
- Bladder Cancer
- Skin Cancers
- Bladder (Urothelial, Transitional Cell) Cancer
- Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
- Urinary Bladder Neoplasms
- Skin Neoplasms
|Stanford University School of Medicine
||Stanford, California 94305-5317